… research projects devoted to finding new treatments for dyskinesia, and improving the delivery of levodopa into the … supported a D1 agonist as a potential therapy for dyskinesia. Dyskinesia is still a major adverse effect of levodopa for …

… models of Parkinson's disease and L-DOPA-induced dyskinesia. Morari is known for his studies of basal ganglia function in parkinsonism and dyskinesia, where he combined two experimental approaches, …

… started . Learn more about PPMI . Treating Complications : Dyskinesia is uncontrolled, involuntary movement that may … to test a medication, dipraglurant, as a treatment for dyskinesia in Parkinson’s disease. The Michael J. Fox … trial is recruiting 140 participants with Parkinson’s and dyskinesia at sites across the United States. The trial will …

… address both motor symptoms, as well as L-dopa-induced dyskinesias. The team, with previous MJFF funding, has … or prevent the motor symptoms of PD, and L-dopa-induced dyskinesias. This treatment provides a scalable autologous … the motor symptoms of Parkinson's and L-dopa-induced dyskinesias. It could provide a scalable cell replacement …

… trials testing a novel treatment for levodopa-induced dyskinesias. His work focuses on preclinical models to test novel pharmacological treatments for levodopa-induced dyskinesias, a major side effect of Parkinson’s disease (PD) …

… is not working optimally and symptoms return) and/or dyskinesia (involuntary, uncontrolled movement). Pros Duopa … blood (and therefore in the brain) to lessen "off" time and dyskinesia. For people who experience significant "off" time and dyskinesia and who do not want to or cannot undergo deep …